FDx Advisors Inc. Has $208,000 Position in Nu Skin Enterprises, Inc. (NYSE:NUS)

FDx Advisors Inc. reduced its holdings in Nu Skin Enterprises, Inc. (NYSE:NUSGet Rating) by 8.2% during the 1st quarter, HoldingsChannel reports. The firm owned 4,355 shares of the company’s stock after selling 388 shares during the quarter. FDx Advisors Inc.’s holdings in Nu Skin Enterprises were worth $208,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. JPMorgan Chase & Co. lifted its stake in shares of Nu Skin Enterprises by 62.9% in the fourth quarter. JPMorgan Chase & Co. now owns 295,510 shares of the company’s stock valued at $14,997,000 after buying an additional 114,061 shares during the period. Meritage Portfolio Management bought a new stake in shares of Nu Skin Enterprises in the fourth quarter valued at about $219,000. Yousif Capital Management LLC bought a new stake in shares of Nu Skin Enterprises in the fourth quarter valued at about $1,417,000. Mutual of America Capital Management LLC lifted its stake in shares of Nu Skin Enterprises by 0.8% in the fourth quarter. Mutual of America Capital Management LLC now owns 44,576 shares of the company’s stock valued at $2,262,000 after buying an additional 363 shares during the period. Finally, Walleye Capital LLC bought a new stake in shares of Nu Skin Enterprises in the fourth quarter valued at about $1,345,000. 93.79% of the stock is owned by institutional investors and hedge funds.

Nu Skin Enterprises Stock Down 0.6 %

Shares of NUS opened at $43.51 on Friday. The stock has a market cap of $2.18 billion, a price-to-earnings ratio of 16.11 and a beta of 1.21. The company has a quick ratio of 0.95, a current ratio of 1.72 and a debt-to-equity ratio of 0.28. Nu Skin Enterprises, Inc. has a 12 month low of $39.40 and a 12 month high of $56.76. The company has a 50-day moving average price of $44.32 and a two-hundred day moving average price of $46.79.

Nu Skin Enterprises (NYSE:NUSGet Rating) last announced its quarterly earnings results on Wednesday, May 4th. The company reported $0.76 EPS for the quarter, topping analysts’ consensus estimates of $0.73 by $0.03. The firm had revenue of $604.90 million during the quarter, compared to analysts’ expectations of $579.70 million. Nu Skin Enterprises had a net margin of 5.28% and a return on equity of 22.05%. The company’s revenue for the quarter was down 10.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.91 earnings per share. Equities analysts predict that Nu Skin Enterprises, Inc. will post 3.57 EPS for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 8th. Stockholders of record on Friday, May 27th were issued a dividend of $0.385 per share. This represents a $1.54 annualized dividend and a dividend yield of 3.54%. The ex-dividend date was Thursday, May 26th. Nu Skin Enterprises’s payout ratio is 57.04%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. TheStreet upgraded shares of Nu Skin Enterprises from a “c+” rating to a “b” rating in a research note on Tuesday, June 7th. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Wednesday, June 22nd. Two analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $61.50.

Insider Transactions at Nu Skin Enterprises

In other news, Chairman Steven Lund sold 51,300 shares of the firm’s stock in a transaction that occurred on Monday, June 13th. The shares were sold at an average price of $43.83, for a total transaction of $2,248,479.00. Following the completion of the sale, the chairman now owns 27,200 shares of the company’s stock, valued at $1,192,176. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In related news, Chairman Steven Lund sold 51,300 shares of the firm’s stock in a transaction that occurred on Monday, June 13th. The shares were sold at an average price of $43.83, for a total value of $2,248,479.00. Following the completion of the sale, the chairman now owns 27,200 shares of the company’s stock, valued at $1,192,176. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Andrew D. Lipman sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, May 23rd. The shares were sold at an average price of $44.95, for a total transaction of $44,950.00. Following the completion of the sale, the director now directly owns 70,214 shares of the company’s stock, valued at approximately $3,156,119.30. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 148,143 shares of company stock valued at $6,647,717. Corporate insiders own 2.80% of the company’s stock.

Nu Skin Enterprises Profile

(Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Featured Stories

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUSGet Rating).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.